• In early May 2026, Qualys reported first-quarter 2026 results showing revenue of US$175.64 million and net income of US$50.64 million, alongside higher full-year revenue and adjusted EPS guidance.
• The company also emphasized traction for its AI-native Risk Operations Center and Enterprise TruRisk Management solution, and launched a Converge partnership that links strong security hygiene to potential cyber insurance premium reductions.
• We’ll now examine how this raised guidance and AI-focused product momentum may influence Qualys’ existing investment narrative and outlook.

AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Qualys Investment Narrative Recap

To own Qualys, you need to believe its cloud platform and AI-native risk operations focus can keep it relevant in an AI-heavy cybersecurity market, while maintaining solid profitability. The Q1 2026 beat and higher full-year guidance support that thesis in the near term, but do not remove key risks around vendor consolidation with hyperscalers and the uncertain impact of new Flex pricing on revenue visibility.

The newly announced Converge partnership is especially relevant here, because it ties Enterprise TruRisk Management directly to potential cyber insurance premium reductions. That helps reinforce the core catalyst behind Qualys’ story: turning its AI-enabled risk visibility and automation into tangible economic value for customers, which can support upsell into the Risk Operations Center and broaden adoption despite intensifying competition and evolving customer buying patterns.

But while the quarter looked solid, investors should still watch how hyperscaler security bundles could pressure Qualys’ role in larger platform deals and...

Qualys' narrative projects $824.8 million revenue and $224.3 million earnings by 2029. This requires 7.2% yearly revenue growth and about a $26 million earnings increase from $198.3 million today.

Uncover how Qualys' forecasts yield a $135.91 fair value, a 50% upside to its current price.

Exploring Other Perspectives

You can see how cautious the lowest analysts were, assuming only about 7 percent annual revenue growth and margins easing to roughly 25 percent, yet even that more pessimistic view could shift after a quarter like this, so it is worth comparing those expectations with your own and considering how both the upbeat guidance and the risk of cloud providers embedding more security directly might reshape the story.

Explore 4 other fair value estimates on Qualys - why the stock might be worth as much as 50% more than the current price!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Qualys research is our analysis highlighting 4 key rewards that could impact your investment decision.
• Our free Qualys research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Qualys' overall financial health at a glance.

No Opportunity In Qualys?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• Outshine the giants: these 19 early-stage AI stocks could fund your retirement.
• Find 45 companies with promising cash flow potential yet trading below their fair value.
• Rare earth metals are the new gold rush. Find out which 31 stocks are leading the charge.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.